{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T16:38:26Z","timestamp":1720543106966},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0180961","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T17:41:02Z","timestamp":1500918062000},"page":"e0180961","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy"],"prefix":"10.1371","volume":"12","author":[{"given":"Jeannine M.","family":"Refos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alieke G.","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian T.","family":"ten Kate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Eadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri A.","family":"Verbrugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma A. J. M.","family":"Bakker-Woudenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy W. J.","family":"van de Sande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.drup.2006.01.001","article-title":"Update on antifungal drug resistance mechanisms of Aspergillus fumigatus","volume":"8","author":"G Chamilos","year":"2005","journal-title":"Drug Resist Updat"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2217\/fmb.11.4","article-title":"Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?","volume":"6","author":"E Snelders","year":"2011","journal-title":"Future Microbiol"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"B De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"TF Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/14787210.4.2.325","article-title":"Echinocandin antifungals: review and update","volume":"4","author":"VA Morrison","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1439-0507.2005.01131.x","article-title":"Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin","volume":"48","author":"G Maschmeyer","year":"2005","journal-title":"Mycoses"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/EC.00041-08","article-title":"Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance","volume":"7","author":"LE Cowen","year":"2008","journal-title":"Eukaryot Cell"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/AAC.01154-08","article-title":"Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus","volume":"53","author":"JR Fortwendel","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/2319-4170.113230","article-title":"Structure, function and regulation of the hsp90 machinery","volume":"36","author":"J Li","year":"2013","journal-title":"Biomed J"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bbamcr.2011.09.003","article-title":"The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones","volume":"1823","author":"J Li","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"ref11","first-page":"310","article-title":"Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus","volume":"42","author":"F Lamoth","year":"2016","journal-title":"Crit Rev Microbiol"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"L Whitesell","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","article-title":"Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?","volume":"18","author":"L Neckers","year":"2012","journal-title":"Clinical Cancer Research"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1073\/pnas.0813394106","article-title":"Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease","volume":"106","author":"LE Cowen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1128\/EC.00032-12","article-title":"Heat shock protein 90 is required for conidiation and cell wall integrity in Aspergillus fumigatus","volume":"11","author":"F Lamoth","year":"2012","journal-title":"Eukaryot Cell"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1128\/AAC.00536-07","article-title":"Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis","volume":"52","author":"WW van de Sande","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/jac\/dkl015","article-title":"Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis","volume":"57","author":"W van Vianen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"ref18","article-title":"Rat model of Invasive Pulmonary Aspergillosis in Handbook of animal models of infection","author":"ACAP Leenders","year":"1999"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jac\/dkf010","article-title":"Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response","volume":"49","author":"MJ Becker","year":"2002","journal-title":"J Antimicrob Chemoth"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1128\/AAC.50.5.1852-1854.2006","article-title":"Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis","volume":"50","author":"EJ Ruijgrok","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1128\/AAC.01556-08","article-title":"Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin","volume":"53","author":"WW van de Sande","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1211\/jpp.57.10.0007","article-title":"Nebulization of four commercially available amphotericin B formulations in persistently granulocytopenic rats with invasive pulmonary aspergillosis: evidence for long-term biological activity","volume":"57","author":"EJ Ruijgrok","year":"2005","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jac\/48.1.89","article-title":"Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats","volume":"48","author":"EJ Ruijgrok","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"ref24","unstructured":"NCCLS. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. NCCLS document M38-A, NCCLS, Wayne, Pa: 2002."},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/13693780802713497","article-title":"The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus","volume":"48","author":"WW van de Sande","year":"2010","journal-title":"Med Mycol"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0732-8893(02)00473-X","article-title":"Comparison of methods of interpretation of checkerboard synergy testing","volume":"44","author":"CR Bonapace","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/AAC.42.4.744","article-title":"Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics","volume":"42","author":"JG den Hollander","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1439-0507.2009.01695.x","article-title":"The utility of a nebulised intra-tracheal rat model of invasive pulmonary aspergillosis","volume":"52","author":"J Chandenier","year":"2009","journal-title":"Mycoses"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13693780500271749","article-title":"Pathophysiology of unilateral pulmonary aspergillosis in an experimental rat model","volume":"44","author":"MJ Becker","year":"2006","journal-title":"Med Mycol"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.bmc.2008.10.087","article-title":"Discovery and development of heat shock protein 90 inhibitors","volume":"17","author":"T Taldone","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"ref31","first-page":"84","article-title":"Chapter 4: Targeting the Molecular Chaperone Heat Shock protein","volume":"90","author":"HL Kaufman","year":"2008"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1186\/1756-9966-33-16","article-title":"Geldanamycin-mediated inhibition of heat shock protein 90 partially activates dendritic cells, but interferes with their full maturation, accompanied by impaired upregulation of RelB","volume":"33","author":"S Trojandt","year":"2014","journal-title":"J Exp Clin Canc Res"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/art.10780","article-title":"Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcripts","volume":"48","author":"S Wax","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0965-1748(02)00092-9","article-title":"Insect hemocytes and their role in immunity","volume":"32","author":"MD Lavine","year":"2002","journal-title":"Insect Biochem Molec"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"e75848","DOI":"10.1371\/journal.pone.0075848","article-title":"Evidence supporting a role for mammalian chitinases in efficacy of caspofungin against experimental aspergillosis in immunocompromised rats","volume":"8","author":"PE Verwer","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"e1000471","DOI":"10.1371\/journal.ppat.1000471","article-title":"Hsp90 orchestrates stress response signaling governing fungal drug resistance","volume":"5","author":"LE Cowen","year":"2009","journal-title":"PLoS Pathog"},{"issue":"24","key":"ref37","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1128\/MCB.20.24.9262-9270.2000","article-title":"Role of HSP90 in salt stress tolerance via stabilization and regulation of calcineurin","volume":"20","author":"J Imai","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/13693786.2012.725481","article-title":"Hsp90 regulates Paracoccidioides brasiliensis proliferation and ROS levels under thermal stress and cooperates with calcineurin to control yeast to mycelium dimorphism","volume":"51","author":"TG Matos","year":"2013","journal-title":"Med Mycol"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10096-010-1118-5","article-title":"Calcineurin-dependent galactomannan release in Aspergillus fumigatus","volume":"30","author":"MA Mennink-Kersten","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref40","article-title":"Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis","author":"F Bugli","year":"2013","journal-title":"Clinical & Developmental Immunology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0180961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T14:33:39Z","timestamp":1569940419000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0180961"}},"subtitle":[],"editor":[{"given":"Olaf","family":"Kniemeyer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0180961","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]}}}